LevMax 2.0 (2023)

LevMax 2.0 closed in early 2023, investing in six Alberta-based researchers from the LevMax-Health: Tri-Agency Fall 2022 competition. The total value for all six projects is $4.8 million with $3.3 million contributed from Alberta Innovates. Projects will run from February 2023 to January 2026.

Project at a Glance

Sector: Health & Life Sciences
Program: LevMax-Health

2023 Recipients of LevMax-Health: Tri-agency Fall 2022 Competition

Lead Applicant LevMax-Health Stream Project Title Contact
Athanasios Zovoilis, MD, PhD, ULethbridge LevMax-Health: Tri Agency Fall 2022 Fusing imaging of neural and behavioral activity with third generation sequencing and single cell epitranscriptome analysis View their website
Bo Cao, PhD, UAlberta LevMax-Health: Tri Agency Fall 2022 Individualized prospective prediction of opioid overdose using machine learning View their website
Carla Prado,
PhD, UAlberta		 LevMax-Health: Tri Agency Fall 2022 Using a Novel, Digital, and Multimodal Platform to Optimize Waist Circumference, Body Composition and Cardiovascular Health in Endometrial Cancer Survivors View their website
David Campbell, MD, PhD, UCalgary LevMax-Health: Tri Agency Fall 2022 Preventing medication complications during AcUte illness through Symptom Evaluation and sick day guidance: A Patient-Centered Digital Health Intervention View their website
Kara Schick-Makaroff,
PhD, UAlberta		 LevMax-Health: Tri Agency Fall 2022 “Re: CBT Dialysis” – A realist evaluation: Why, for whom, in what circumstances does CBT work for people with depressive symptoms receiving dialysis? View their website
Tolulope Sajobi, PhD, UCalgary LevMax-Health: Tri Agency Fall 2022 Characterizing patient preferences and personalizing risk information for optimal patient-centered management of coronary artery disease View their website